Antioxidant status in advanced cervical cancer patients undergoing neoadjuvant chemoradiation

British Journal of Biomedical Science

Volumn 64, Issue 1, 2007, Pages 23-27

  Sharma, Alpana ^a   Rajappa, M ^b   Saxena, A ^c   Sharma, M ^c  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c MAULANA AZAD MEDICAL COLLEGE   (India)

Author keywords

Antioxidants; Catalase; Cervical neoplasms; Drug therapy; Glutathione; Lipid peroxides; Neoadjuvant therapy; Superoxide dismutase

Indexed keywords

ALKADIENE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; LIPID PEROXIDE; SUPEROXIDE DISMUTASE;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD SAMPLING; CANCER ADJUVANT THERAPY; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR GROWTH; UTERINE CERVIX CANCER;

EID: 34250707858     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2007.11732751     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Das BC, Gopalkrishna V, Suresh H et al. Cancer of the uterine cervix and human papillomavirus infection. Current Science 2000; 78: 52-63.
3. Stern E, Forsythe AB, Youkeles L et al. Steroid contraceptive use and cervical dysplasia: increased risk of progression. Science 1977; 196: 1460-2.
4. Jayant K. Additive effect of two risk factors in the etiology of cancer of the cervix uteri. Br J Cancer 1987; 56: 685-6.
5. Eastwood MA. Interaction of dietary antioxidants in vivo: how fruits and vegetables prevent disease. QJM 1999; 92: 527-30.
6. Trevathan E, Layde P, Webster LA et al. Cigarette smoking and dysplasia and carcinoma in situ of the uterine cervix. JAMA 1983; 250: 499-502.
7. Rotkin ID. Adolescent coitus and cervical cancer: associations of related events with increased risk. Cancer Res 1967; 27: 603-17.
8. Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
9. Walboomers JMM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
10. Munoz N, Bosch FX, de Sanjose et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
11. Cerutti P, Trump B. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 1991; 3: 1-5.
12. Punnonen R, Kudo R, Punnonen K et al. Activities of antioxidant enzymes and lipid peroxidation in endometrial cancer. Eur J Cancer 1993; 29A: 266-9.
13. Casaril M, Corso F, Corrocher R. Free radicals in human pathology (in Italian). Recenti Prog Med 1991; 82: 39-44.
14. Florence TM. The role of free radicals in disease. Aust NZ J Ophthalmol 1995; 23: 3-7.
15. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Clarendon Press, 1985.
16. Mates JM, Perez-Gomez C, de Castro IN. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32: 595-603.
17. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Radic Biol Med 1990; 8: 583-99.
18. Mukundan H, Bahadur AK, Kumar A et al. Glutathione level and its relation to radiation therapy in patients with cancer of the uterine cervix. Ind J Exp Biol 1999; 37: 859-64.
19. Bhuvarahamurthy V, Balasubramanian N, Govindasamy S. Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human cervical carcinoma. Mol Cell Biochem 1996; 158: 17-23.
20. Ito H. Radiotherapy for cervical cancer: a multi-institutional comparison. Nippon Igaku Oshasen Gokkai Zasshi 1999; 59: 745-9.
21. Kish JA, Ensley JF, Jacobs J et al. A randomized trial of cisplatin and 5FU infusion and CACP and 5FU bolus for recurrent and advanced SCC of the head and neck. Cancer 1985; 56: 27-40.
22. Hercbergs A, Brok F, Simoni J et al. Erythrocyte glutathione and tumour response to chemotherapy. Lancet 1992; 339: 1074-6.
23. International Federation of Gynecology and Obstetrics. Staging announcement: FIGO staging of gynecologic cancers, cervical and vulva. Int J Gynecol Cancer 1995; 5: 19-26.
24. Sharma JB, Sharma A, Bahadur A et al. Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet 2006; 94: 23-7.
25. Yagi K. Lipid peroxides and human disease. Chem Physiol Lipids 1978; 45: 337-51.
26. Rao KS, Recknagel RO. Early onset of lipid peroxidation in rat liver after carbon tetrachloride administration. Exp Mol Pathol 1968; 9: 271-8.
27. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-7.
28. Paglia DE, Valentine WN. Study on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
29. Habig WH, Pabst MJ, Jakoby WB. Glutathione-S-transferase the first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-9.
30. Beutler E. Red cell metabolism: a manual of biochemical methods (2nd edn). New York: Grune and Stratton, 1975: 66-9.
31. Sinha KA. Colorimetric assay of catalase. Anal Biochem 1972; 47: 389-94.
32. Drabkin DL, Austin J. Spectrophotometric studies, spectrophotometric constants for common hemoglobin derivatives in human, dog and rabbit blood. J Biol Chem 1932; 98: 719-33.
33. Kruskal WH, Wallis WA. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952; 47: 583-621.
34. Kolangiappan K, Manoharan S, Kayalvizhi M. Lipid peroxidation antioxidants and osmotic fragility in cervical cancer patients. Clin Chim Acta 2002; 326: 143-9.
35. Gonzalez RA. Free-radicals, oxidative stress and DNA metabolism in human cancer. Cancer Invest 1999; 17: 376-7.
36. Cramer DW, Kuper H, Harlow BL et al. Carotenoids, antioxidants and ovarian cancer risk in pre- and post-menopausal women. Int J Cancer 2001; 94: 128-34.
37. Manoharan S, Kolanjiappan K, Kayalvizhi et al. Lipid peroxidation and antioxidant status in cervical cancer patients. J Biochem Mol Biol Biophys 2002; 6: 225-7.
38. Mila-Kierzenkowska C, Kornatowska KK, Wozniak A et al. The effect of brachytherapy on antioxidant status and lipid peroxidation in patients with cancer of the uterine cervix. Cell Mol Biol Lett 2004; 9: 511-8.
39. Kumaragurparan R, Subapriya R, Kabalimoorthy J et al. Antioxidant profile in circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin Biochem 2002; 35: 275-9.
40. Cabelguenne A, Loriot M, Stucker I et al. Glutathione-associated enzymes in head and neck carcinoma and response to neoadjuvant chemotherapy. Int J Cancer 2001; 93: 725-30.
41. Senthil K, Aranganathan S, Nalini N. Evidence of oxidative stress in the circulation of ovarian cancer patients. Clin Chim Acta 2004; 339: 27-32.
42. Kaynar H, Meral M, Turhan H et al. Glutathione-peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, superoxide dismutase, total glutathione, nitric oxide and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett 2005; 227: 133-9.
43. Devi GS, Prasad MH, Saraswathi I et al. Free radical antioxidant enzymes and lipid peroxidation in different types of leukemias. Clin Chim Acta 2000; 293: 53-62.
44. Sun Y, Li Y, Oberley LW et al. Superoxide dismutase activity during dimethyl hydrazine carcinogenesis and the effects of choline and indole. Free Rad Res Comms 1988; 4: 299-310.
45. Buzby GP, Mullen JL, Steih TP et al. Host tumor interactions and nutrient supply. Cancer 1980; 45: 2940-7.
46. Tormos C, Chaves FJ, Garcia MJ et al. Role of glutathione in the induction of apoptosis and c-fos and c-jun mRNAs by oxidative stress in tumor cells. Cancer Lett 2004; 208: 103-13.
47. Scott MD, Lubin BH, Linzuo et al. Erythrocyte defense against hydrogen peroxide: pre-eminent importance of catalase and superoxide dismutase. J Lab Clin Med 1991; 118: 7-16.
48. Oberley LW, Buettner GR. Role of superoxide dismutase in cancer. Cancer Res 1979; 39: 1141-9.
49. Kumaraguruparan R, Subapriya R, Viswanathan P et al. Tissue lipid peroxidation and antioxidant status in patients with adenocarcinoma of the breast. Clin Chim Acta 2002; 325: 165-70.